Funded Tech Companies
Prologue Medicines
Wondering who provided funding to Prologue Medicines? Flagship Pioneering joined the equity holders in this life sciences company.
Company Overview
Company Name
Prologue Medicines
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Cambridge, MA Undisclosed
USA
Cambridge, MA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
At Prologue, we are going beyond the human proteome to uncover proteins that have been evolved by viruses with the potential to modulate human physiology and achieve outcomes that human proteins, even designed proteins, cannot. By co-opting viral evolution, we can discover novel proteins with enhanced properties that expand the functional boundaries of proteins encoded by our own genome and learn their design rules to create programmable medicines with desirable features.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/7/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lovisa Afzelius
Chief Scientific Officer
Hozefa Bandukwala
President
Theonie Anastassiadis
Vice President
Nirmal Keshava
Vice President
Angela Norton
Vice President
Rakesh Verma
Company Investors
Browse more funded tech companies:
ProLogium Technology | Prolucent Health
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs